NEWS

News Articles

Quest Diagnostics trades remaining stake in Q2 Solutions to IQVIA for $760M

April 1, 2021

Nearly six years after launching a joint venture with IQVIA’s contract research progenitor, Quintiles, Quest Diagnostics is handing over the remainder of its minority share in return for $760 million in cash. The two companies formed Q2 Solutions in 2015 to provide global biopharma companies with the lab tests needed to run clinical trials and get their…

Read More

GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent

April 1, 2021

Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA – (NewMediaWire) – April 01, 2021 – GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance…

Read More

Blink President Pens Letter to Biden Administration in Support of Ongoing COVID Testing

April 1, 2021

Blink Science President Eric Doherty sent a letter to President Biden yesterday in the wake of the announcement that a fourth wave of the coronavirus is taking hold in the US. “Despite extraordinary efforts to get vaccinations into the arms of our citizens, a fourth wave of coronavirus infections has begun, with the CDC reporting an average of 65,000…

Read More

Amgen saddles up with Rodeo for a $55M trek into regenerative medicine

March 30, 2021

Amgen is adding an arrow to its anti-inflammatory quiver with its buyout of Seattle’s Rodeo Therapeutics. The deal will see just $55 million change hands upfront, but another $666 million could come into play if Rodeo’s assets live up to their hype. Amgen will get its hand on Rodeo’s stable of assets targeting prostaglandin, a…

Read More

What’s Behind the Hispanic Vaccination Gap?

March 29, 2021

Hispanic people across the United States continue to be especially underrepresented among those vaccinated for Covid-19, according to a New York Times analysis of state-reported race and ethnicity information. The Hispanic share of the vaccinated population is less than the Hispanic general population in all states with large Hispanic communities. Barriers to vaccine access faced in many…

Read More

‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective

March 29, 2021

Anew study suggests the messenger RNA vaccines produced by Moderna and the Pfizer-BioNTech partnership appeared to be 90% effective in preventing Covid-19 infection in a real-world setting. The study was released Monday in Morbidity and Mortality Weekly Report, an online journal published by the Centers for Disease Control and Prevention. The study followed nearly 4,000 health care workers,…

Read More